IVVDInvivyd, Inc.

$257M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$248M

Net Income

-$241M

EPS (Diluted)

$-2.17

Cash Flow

Operating Cash Flow

-$220M

Free Cash Flow

-$222M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$383M

Total Liabilities

$27M

Stockholders' Equity

$356M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$248M	-$227M	-9.3%
Net Income	-$241M	-$227M	-6.4%

IVVD FY 2022 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena